A double-blind, placebo-controlled, randomized, crossover pilot study of thesafety and short-term antisialorrheic efficacy of multiple doses of intra-oral tropicamide films in Parkinson\'s disease
2011-09-10 - English - Poster Session 1: Movement disorders 1

Background: Sialorrhea is a common non-motor symptom in PD. Short-acting antimuscarinic, such as tropicamide, may reduce saliva secretion without the side effects associated with long-acting antimuscarinics.
Objective: To explore the anti-sialorrhea effect of single doses...(more)

Adverse events toantiparkinsonian medications in parkinsonian and non-parkinsonian patients
2011-09-10 - English - Poster Session 2: Movement disorders 2

Introduction: Underreporting of adverse drug reactions (ADRs) usually reaches 90%.
Objective: To explore the gap in the frequency of ADRs to antiparkinsonian drugs (APDs) in Parkinson’s disease (PD) and non-PD patients when explored by means of a full extensive...(more)

Impulse-control disorders in Parkinson\'s disease patients
2011-09-10 - English - Poster Session 2: Movement disorders 2

Background: Impulse-control disorders (ICD) can occur with any dopaminergic drug in Parkinson\'s Disease (PD), specially in younger patients.
Objective: To assess the prevalence of ICD in a sample of PD and non-PD patients and to evaluate the factors related to their...(more)

Factors related toorthostatic hypotension in Parkinson\'s disease
2011-09-10 - English - Poster Session 2: Movement disorders 2

Introduction: Orthostatic hypotension (OH), a frequent feature of Parkinson’s disease (PD) can contribute to falls and is related to the disease itself or to drugs.
Objectives: To assess the concordance between abnormal BP fall after orthostatism and the presence of...(more)